Benefits and Risks of Early Antiretroviral Treatment Initiation and 6-Months Isoniazid Prophylaxis in HIV-Infected West African Adults : a Randomized Factorial Trial (ANRS 12136 TEMPRANO)
Latest Information Update: 17 May 2022
At a glance
- Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Isoniazid; Lopinavir/ritonavir
- Indications HIV-1 infections; HIV-2 infections; Tuberculosis
- Focus Therapeutic Use
- Acronyms TEMPRANO
- 26 Jul 2017 Results assessing association between HIV-1-DNA and mortality in HIV-infected adults presented at the 9th International AIDS Society Conference on HIV Science
- 26 Jul 2017 Results assessing association between inflammatory/coagulation biomarkers and mortality in HIV-infected adults with high CD4 counts presented at the 9th International AIDS Society Conference on HIV Science
- 02 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.